EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Amorepacific Corp. (New) (090430) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Amorepacific Corp. (New) KRW 84,785, price KRW 142,500, upside -40.5%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Consumer Defensive · KR · ISIN KR7090430000

AC Some data Sep 24, 2026

Amorepacific Corp. (New)

090430 · KO

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value 84,785 KRW · Strongly overvalued (−41%)
Quality 67/100
!Weak Growth (revenue 5y −0.8 %/yr)
!Thin margins · 5.4% net margin (TTM)
Low debt · generates free cash flow
·0.87% dividend yield
Ranks above peers (6/10)
!Narrow moat 40/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 18 out of 100
!Weak on dividend: 17 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

286,430 KRW 86,991 KRW Fair Value 84,785 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 86,991 KRW – 286,430 KRW · fair‑value band 69,664 KRW – 105,981 KRW · the 142,500 KRW price screens above the 84,785 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Amorepacific Corp. (New) in your weekly email

Every Wednesday you see whether Amorepacific Corp. (New) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Amorepacific Corporation researches, develops, manufactures, markets, sells, and trades cosmetics and beauty products worldwide.

Show more

Amorepacific Corporation researches, develops, manufactures, markets, sells, and trades cosmetics and beauty products worldwide. It offers cosmetics under the Sulwhasoo, Laneige, Innisfree, AP Beauty, Hera, Primera, Iope, Mamonde, Hanyul, espoir, Etude, Odyssey, Be Ready, Holitual, Tata Harper, and Cosrx brands; medical beauty products under the Aestura brand; beauty devices under the maekON brand; and inner beauty products under the VitalBeautie brand. The company also provides hair beauty products under the Ryo, Mise-en-Scène, Labo-H, Ayunche, Amos Professional, and Longtake brands; body care products under the Illiyoon, Hapy Bath, and Skin U brands; dental care products under the Median and Gentist brands; and tea products under the Osulloc brand. In addition, it engages in the manufacture and sale of detergent, and organic and inorganic compounds; manufacture, processing, and trade of food and other products; product packaging and facility management; and equipment design and production. The company is headquartered in Seoul, South Korea.

Stock analysis

Amorepacific Corp. (New) (090430) currently trades at 142,500 KRW, while our model-based Fair Value estimate is 84,785 KRW, implying the stock looks roughly 68.1% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 110,248 KRW per share, and 2 of the 23 models we run sit above the 142,500 KRW price.

Bear case: the Earnings-Based group reads lowest at 51,605 KRW, and 21 of the 23 models stay below the price. Evidence for this calculation is medium.

Scenario range: 69,664 KRW (bear) to 105,981 KRW (bull), the price of 142,500 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 67/100 (solid quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Amorepacific Corp. (New) reported revenue of 4.3T KRW in FY2025 versus 4.9T KRW in FY2021, a compound −3.3%/yr. Reported net income was 236B KRW in FY2025, compounding +5.0%/yr from FY2021.

Key figures

Market cap 8.3T KRW (≈ $5.8B) · P/S ratio 1.98 · Dividend yield 0.9% · Net margin 5.5% · Return on equity 4.4% · Return on assets (EBIT) 3.9% · Operating margin 11.2% · Revenue (TTM) 4.3T KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 13% below its 52-week high and 48% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −25% fair-value upside, at −41%, 090430 screens richer than that median.

Fair Value models

Bear 69,664 KRW Fair Value 84,785 KRW Bull 105,981 KRW
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 97,130 KRW 134,989 KRW 187,068 KRW 81
Growth DCF 99,300 KRW 134,066 KRW 179,723 KRW 79
Owner Earnings 83,131 KRW 115,029 KRW 158,909 KRW 77
All 23 models by family
DCF Models
FCF DCF 97,130 KRW 134,989 KRW 187,068 KRW 81
Owner Earnings 83,131 KRW 115,029 KRW 158,909 KRW 77
5Y Revenue Exit 72,272 KRW 99,416 KRW 132,304 KRW 73
5Y EBITDA Exit 96,781 KRW 143,221 KRW 195,029 KRW 75
5Y P/E Exit 76,376 KRW 106,751 KRW 136,807 KRW 72
10Y Revenue Exit 79,620 KRW 105,388 KRW 136,505 KRW 68
10Y EBITDA Exit 96,073 KRW 134,407 KRW 181,383 KRW 69
10Y P/E Exit 83,579 KRW 110,248 KRW 139,727 KRW 65
Earnings-Based
Graham-Dodd 27,454 KRW 66,557 KRW 86,015 KRW 65
PEG = 1.0 11,813 KRW 16,876 KRW 21,939 KRW 57
EPV 45,689 KRW 51,605 KRW 56,709 KRW 74
Multiples
P/E Multiple 63,589 KRW 84,785 KRW 105,981 KRW 63
P/S Multiple 51,476 KRW 68,635 KRW 85,794 KRW 58
P/B Multiple 51,476 KRW 68,635 KRW 85,794 KRW 55
EV/EBIT 81,570 KRW 106,020 KRW 130,469 KRW 66
EV/EBITDA 109,086 KRW 142,707 KRW 176,329 KRW 67
EV/Revenue 60,572 KRW 83,008 KRW 105,444 KRW 54
Asset-Based
NCAV (Graham) 46,674 KRW 62,544 KRW 93,349 KRW 54
Growth DCF
Growth DCF 99,300 KRW 134,066 KRW 179,723 KRW 79
Rev-Margin DCF 72,272 KRW 100,724 KRW 131,838 KRW 73
Economic Profit
Residual Income 69,114 KRW 68,479 KRW 61,676 KRW 76
ROIC Compounder 45,689 KRW 51,605 KRW 56,709 KRW 72
Growth Earnings
Growth-Adj P/E 48,562 KRW 69,374 KRW 90,186 KRW 67

Open the full fair value analysis →

Notify me when 090430 reaches fair value

Put 090430 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 67/100

Of which business quality 67 · Market factors (momentum, volatility) 58

Profitability 43
Margins and returns on capital today
Quality Growth 37
Are margins and returns improving?
Cashflow 73
Earnings quality: real cash, not paper profit
Fin. Strength 84
Balance sheet, leverage, solvency risk
Investment 82
Disciplined investing over empire-building
Low Volatility 42
Calm price path (market factor)
Momentum 66
Price trend over the last 3–12 months (market factor)
52W Momentum 63
Distance to the 52-week high (market factor)
Net Issuance 90
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+9.5%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.8%
Start year 2020 (pandemic). Over 10 years: −1.1% a year
Revenue growth 19 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.3%
What shareholders gained per year (last 5 years), in KRW (mathematically smoothed) What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+47.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+46.1%
Dividend (yield on the price)0.9%
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 8%
2025 sits 55% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
⚠ Revenue per share shrinking 5.0%/yr over ~6Y (margins eroding too) Structural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Growth Forecast

Price in line with expectations
The price assumes more growth than the company has delivered so far and about what analysts expect.
What the price assumes This turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+7.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect Analysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+6.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +5.1% a year for the price and +4.7% for the forecasts.
Forecast 2026 (sales)+8.4%
Forecast 2027 (sales)+7.6%
Projected 2028 (sales)+6.9%
Projected 2029 (sales)+6.2%
Projected 2030 (sales)+5.5%

090430 screens 68% overvalued. Compare with The Procter & Gamble Company →

Compare Amorepacific Corp. (New) with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 251 stocks

Beats the industry median on 6/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 67 · Top 25%
Fair Value upside −41% · Bottom 25%
Profitability
Return on equity (TTM) 4% · Below median
Return on assets 3% · Below median
Net margin (TTM) 5% · Above median
Operating margin (TTM) 11% · Above median
Growth and dividend
Revenue growth 6% · Above median
Dividend yield (TTM) 0.9% · Bottom 25%
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 33
FUTURE (revenue growth)32 · sector 9
PAST (return on equity)18 · sector 27
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)17 · sector 55

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $148.22 $110.45 −25%
Colgate-Palmolive Company CL $87.05 $55.95 −36%
Hindustan Unilever Limited HINDUNILVR ₹1,934 ₹799.52 −59%
Kenvue Inc KVUE $17.86 $12.73 −29%
Kimberly-Clark Corporation KMB $98.91 $83.93 −15%
Henkel AG HEN €69.30 €80.96 +17%
The Estée Lauder Companies Inc EL $100.29 $27.22 −73%
Church & Dwight Co CHD $96.12 $65.12 −32%
Beiersdorf Aktiengesellschaft, BEI €76.46 €68.95 −10%
Puig Brands, S.A PUIG €17.56 €19.32 +10%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Amorepacific Corp. (New) Fair Value". https://www.fairvalue-calculator.com/stock/090430

Frequently asked questions

Is Amorepacific Corp. (New) (090430) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 84,785 KRW versus a price of 142,500 KRW, about −41% upside (overvalued).
What is the fair value of 090430?
Our model-based fair value for Amorepacific Corp. (New) is 84,785 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 142,500 KRW.
What is the quality score of 090430?
Amorepacific Corp. (New) has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Amorepacific Corp. (New) (090430)?
Our model-based price target is the fair value of 84,785 KRW (as of Sep 24, 2026) from 23 valuation models. Cautious scenario 69,664 KRW, optimistic scenario 105,981 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Amorepacific Corp. (New) stock forecast for 2026?
Our models put fair value at 84,785 KRW, about −41% upside versus a price of 142,500 KRW (overvalued). Cautious scenario 69,664 KRW, optimistic scenario 105,981 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Amorepacific Corp. (New) (090430)?
Amorepacific Corp. (New) reported trailing-twelve-month revenue of about 4.3T KRW (latest available figure, as of Sep 24, 2026).
Does Amorepacific Corp. (New) pay a dividend?
Amorepacific Corp. (New) currently shows a dividend yield of about 0.87% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Amorepacific Corp. (New) (090430)?
For today's price to be fair in a discounted-cash-flow model, Amorepacific Corp. (New) would have to grow free cash flow by +7.3 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 090430 use?
Our models discount Amorepacific Corp. (New) at 10.3 %: a base by market capitalisation (mid), damped by beta 1.05, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Amorepacific Corp. (New) that is +7.3 % per year a year over ten years, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has Amorepacific Corp. (New) (090430) delivered so far?
Over the past 5 years revenue at Amorepacific Corp. (New) grew -0.8 % a year. The price currently implies +7.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Amorepacific Corp. (New) (090430) growing?
The median revenue growth in the sector is +2.8 % a year. That is the yardstick for the growth priced into Amorepacific Corp. (New) (+7.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Amorepacific Corp. (New) (090430)?
The free-cash-flow yield on the price is 5.92 %: that much free cash flow Amorepacific Corp. (New) produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Amorepacific Corp. (New) (090430)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Amorepacific Corp. (New) it is 84,785 KRW per share (as of Sep 24, 2026), against a price of 142,500 KRW. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Amorepacific Corp. (New) stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 090430 trades above its calculated fair value: price 142,500 KRW, fair value 84,785 KRW, a gap of about −41% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 090430?
No. The price is what the market pays today (142,500 KRW); the fair value is what the company's own numbers justify (84,785 KRW). For Amorepacific Corp. (New) the two are 57,715 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Amorepacific Corp. (New) worth?
The market values Amorepacific Corp. (New) at about 8.3T KRW (market capitalisation, as of Sep 24, 2026). Per share that is 142,500 KRW; our models calculate a fair value of 84,785 KRW per share.
What do the bullish and bearish scenarios say about 090430?
Our models span a range for Amorepacific Corp. (New): cautious scenario 69,664 KRW, base 84,785 KRW, optimistic 105,981 KRW per share (as of Sep 24, 2026, price 142,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Amorepacific Corp. (New) (090430)?
Balance-sheet figures for Amorepacific Corp. (New) (as of Sep 24, 2026): return on equity 4.4%, debt of 0.01 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 090430 from its 52-week high?
Amorepacific Corp. (New) trades at 142,500 KRW, about 13% below its 52-week high of 163,682 KRW and 48% above the low of 96,200 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 84,785 KRW is for.
Which stocks are comparable to Amorepacific Corp. (New)?
From the same area (Consumer Defensive) we also value The Procter & Gamble Company, Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Amorepacific Corp. (New) stock attractive at the current price?
The data as of Sep 24, 2026: price 142,500 KRW, calculated fair value 84,785 KRW (−41%), Quality Score 67/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 090430 calculated?
We run Amorepacific Corp. (New) through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 84,785 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Amorepacific Corp. (New) itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Amorepacific Corp. (New) (090430)?
The closing price on Sep 23, 2026 was 142,500 KRW. Our model-based fair value is 84,785 KRW, about −41% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Amorepacific Corp. (New) right now?
The price sits above even our optimistic bull case (105,981 KRW). The favourable scenario is already priced in. Solid but not exceptional quality (67/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Amorepacific Corp. (New)

How large is the market capitalisation of Amorepacific Corp. (New) (090430)?
The market capitalisation of Amorepacific Corp. (New) is 8.3T KRW (≈ $5.8B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Amorepacific Corp. (New) (090430)?
The price-to-sales ratio of Amorepacific Corp. (New) is 1.98 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Amorepacific Corp. (New) (090430)?
The dividend yield of Amorepacific Corp. (New) is 0.9%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Amorepacific Corp. (New) (090430)?
The net margin of Amorepacific Corp. (New) is 5.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Amorepacific Corp. (New) (090430)?
The return on equity (ROE) of Amorepacific Corp. (New) is 4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Amorepacific Corp. (New) (090430)?
On an EBIT basis the return on assets of Amorepacific Corp. (New) is 3.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Amorepacific Corp. (New) (090430)?
The operating margin of Amorepacific Corp. (New) is 11.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Amorepacific Corp. (New) (090430)?
Revenue at Amorepacific Corp. (New) is growing +6.4% versus a year earlier (3y avg +0.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Amorepacific Corp. (New) (090430)?
Earnings per share at Amorepacific Corp. (New) are growing −2.0% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch Amorepacific Corp. (New) in the live analysis

One click puts Amorepacific Corp. (New) on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.